RNA-binding protein Nova-1 is a protein that in humans is encoded by the NOVA1 gene.[5][6]
This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described.[6] Both Neanderthals and Denisovans had one version and nearly all modern humans had another suggesting positive selection. Insertion of Neanderthal gene variant of the neuro-oncological ventral antigen 1 (NOVA1) gene into human cortical organoids might promote slower development and higher surface complexity in the brain models,[7] but this may be an artefact of a CRISPR side effect,[8][9] as it could not be replicated in a subsequent study.[10]
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000139910 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000021047 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Buckanovich RJ, Yang YY, Darnell RB (February 1996). "The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies". The Journal of Neuroscience. 16 (3): 1114–1122. doi:10.1523/JNEUROSCI.16-03-01114.1996. PMC 6578795. PMID 8558240.
- 1 2 "Entrez Gene: NOVA1 neuro-oncological ventral antigen 1".
- ↑ "Neanderthal Gene Variant Alters Neurodevelopment in Human Brain Organoids". 11 February 2021.
- ↑ Maricic T, Helmbrecht N, Riesenberg S, Macak D, Kanis P, Lackner M, et al. (October 2021). "Comment on "Reintroduction of the archaic variant of NOVA1 in cortical organoids alters neurodevelopment"". Science. 374 (6565) eabi6060. New York, N.Y. doi:10.1126/science.abi6060. PMID 34648345. S2CID 238990790.
- ↑ Herai RH, Szeto RA, Trujillo CA, Muotri AR (October 2021). "Response to Comment on "Reintroduction of the archaic variant of NOVA1 in cortical organoids alters neurodevelopment"". Science. 374 (6565) eabi9881. New York, N.Y. doi:10.1126/science.abi9881. PMID 34648331. S2CID 238990560.
- ↑ Riesenberg S, Kanis P, Macak D, Wollny D, Düsterhöft D, Kowalewski J, et al. (September 2023). "Efficient high-precision homology-directed repair-dependent genome editing by HDRobust". Nature Methods. 20 (9): 1388–1399. doi:10.1038/s41592-023-01949-1. PMC 10482697. PMID 37474806.
Further reading
- Buckanovich RJ, Posner JB, Darnell RB (1993). "Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system". Neuron. 11 (4): 657–672. doi:10.1016/0896-6273(93)90077-5. PMID 8398153. S2CID 22554933.
- Buckanovich RJ, Darnell RB (1997). "The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo". Molecular and Cellular Biology. 17 (6): 3194–3201. doi:10.1128/MCB.17.6.3194. PMC 232172. PMID 9154818.
- Lewis HA, Chen H, Edo C, Buckanovich RJ, Yang YY, Musunuru K, et al. (February 1999). "Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains". Structure. 7 (2). London: 191–203. doi:10.1016/S0969-2126(99)80025-2. PMID 10368286.
- Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, Okano HJ, et al. (February 2000). "Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability". Neuron. 25 (2): 359–371. doi:10.1016/S0896-6273(00)80900-9. PMID 10719891.
- Dias Neto E, Correa RG, Verjovski-Almeida S, Briones MR, Nagai MA, da Silva W, et al. (March 2000). "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags". Proceedings of the National Academy of Sciences of the United States of America. 97 (7): 3491–3496. Bibcode:2000PNAS...97.3491D. doi:10.1073/pnas.97.7.3491. PMC 16267. PMID 10737800.
- Dredge BK, Darnell RB (2003). "Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer". Molecular and Cellular Biology. 23 (13): 4687–4700. doi:10.1128/MCB.23.13.4687-4700.2003. PMC 164843. PMID 12808107.
- Brandenberger R, Wei H, Zhang S, Lei S, Murage J, Fisk GJ, et al. (June 2004). "Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation". Nature Biotechnology. 22 (6): 707–716. doi:10.1038/nbt971. PMID 15146197. S2CID 27764390.
- Ule J, Ule A, Spencer J, Williams A, Hu JS, Cline M, et al. (August 2005). "Nova regulates brain-specific splicing to shape the synapse". Nature Genetics. 37 (8): 844–852. doi:10.1038/ng1610. PMID 16041372. S2CID 8446567.
- Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, et al. (May 2006). "A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration". Cell. 125 (4): 801–814. doi:10.1016/j.cell.2006.03.032. PMID 16713569.
PDB gallery |
|---|
1dt4: CRYSTAL STRUCTURE OF NOVA-1 KH3 K-HOMOLOGY RNA-BINDING DOMAIN
1ec6: CRYSTAL STRUCTURE OF NOVA-2 KH3 K-HOMOLOGY RNA-BINDING DOMAIN BOUND TO 20-MER RNA HAIRPIN
2ann: Crystal structure (I) of Nova-1 KH1/KH2 domain tandem with 25 nt RNA hairpin
2anr: Crystal structure (II) of Nova-1 KH1/KH2 domain tandem with 25nt RNA hairpin
|